Biomed mainz
WebApr 10, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the … WebMainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of ...
Biomed mainz
Did you know?
WebMar 21, 2024 · BERKELEY, Calif. and MAINZ, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company ... WebAbout us. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily …
WebApr 11, 2024 · What is Mainz Biomed's stock price forecast for 2024? 3 brokerages have issued 1 year target prices for Mainz Biomed's stock. Their MYNZ share price forecasts range from $11.00 to $25.00. On average, they anticipate the company's stock price to reach $17.00 in the next twelve months. WebFeb 21, 2024 · BERKELEY, Calif. and MAINZ, Germany, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the execution of its option from Uni Targeting Research AS to …
WebFeb 21, 2024 · Mainz Biomed is commercializing ColoAlert across Europe and in select international markets through a differentiated business model of partnering with third-party laboratories for test kit ... WebApr 10, 2024 · MYNZ +2.20% + Free Alerts. ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today financial results for the ...
WebMainz Biomed B.V. Ordinary Shares (MYNZ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebJan 3, 2024 · Mainz BioMed NV. BERKELEY, US and MAINZ, Germany , Jan. 03, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic ... the other yellow pagesWebMar 15, 2024 · Mainz Biomed undertakes no obligation to publicly. update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future ... the other you grim dawnWeb21 hours ago · The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mainz Biomed B.V. with a $18.00 average price target, which is a 208.85% upside from current levels. shuffling cards clipartWebApr 10, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the … shuffling cards asmrthe other yijingWebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ... shuffling card soundWebOct 28, 2024 · Mainz BioMed develops market-ready molecular genetic diagnostic solutions for life-threatening... Mainz Biomed B.V. Sirius Gutenberg Park Robert-Koch-Straße 50 55129, Mainz, Germany shuffling bros